Q: Hi, Pat. What do you think of Illinois Tool Works (ITW on NYSE). It seems to be a very consistent and reliable dividend payer. Thanks.

A: Illinois Tool Works, $132.35, symbol ITW on NYSE (Shares outstanding: 331.8 million; Market cap: $43.4 billion; www.itw.com), is a multi-industry manufacturing company operating in 56 countries. Known as ITW, it has roughly 50,000 employees.

The company’s diversified range of industrial products includes aerospace technology, bridges,… Read More

Cannabis in the news October 24, 2018

Read Next Article →
A week after legalization, news on cannabis and cannabis stocks continues to mount up. We carefully filter all of the stories and select the ones that should mean the most to you as a Canadian investor.

1. Desjardins Group—Canada’s largest federation of credit… Read More

11 tips for picking TSX blue chip stocks

11 tips for picking TSX blue chip stocks

TSX Blue Chip Stocks Are Key Components Of Successful Investor Portfolios
TSX blue chip stocks are well-established companies with attractive business prospects on the Toronto Stock Exchange, like Bank of Montreal (TSE: BMO), RioCan Real Estate Investment Trust (TSX: REI.UN), and Enbridge (TSE: ENB). Well-established firms… Read More

These 3 ETFs offer low-fee gold exposure

An improved U.S. economy and low unemployment led the U.S. Federal Reserve to raise interest rates three times in 2017 and twice so far this year. That dampens the risk of a falling U.S. dollar and much-stronger inflation. Typically, both of those factors are needed… Read More

Q: Hi Pat: I would value your opinion on Glaukos Corporation, which makes an effective treatment for glaucoma. I have had one eye successfully treated and am waiting to have the other one done. There are hundreds of thousands of victims of this disease in the world, and no other treatment is as effective. Please comment. Kind regards.

A: Glaukos Corporation, $41.61, symbol GKOS on NYSE (Shares outstanding: 34.9 million; Market cap: $1.4 billion; www.glaukos.com), develops and markets medical devices and therapies to treat glaucoma. That disease is the result of excessive pressure on the eye’s optic nerve; it’s also the leading cause… Read More

Pengrowth loses a listing

PENGROWTH ENERGY $0.97 (Toronto symbol PGF; Shares outstanding: 547.4 million; Market cap: $539.4 million; TSINetwork Rating: Speculative; No dividends paid; www.pengrowth.com) produces oil and natural gas, mostly in Western Canada. This includes its Lindbergh oil sands project in the Cold Lake area of Alberta.
In addition to their… Read More